{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T14:00:35Z","timestamp":1772028035753,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5KL2TR003099-05"],"award-info":[{"award-number":["5KL2TR003099-05"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG000262"],"award-info":[{"award-number":["T32 AG000262"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG000262"],"award-info":[{"award-number":["T32 AG000262"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA293167"],"award-info":[{"award-number":["K08CA293167"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>A low-risk cancer characterized by slow growth and excellent prognosis, papillary thyroid microcarcinoma (PTMC) is increasingly managed with less invasive alternatives to surgical resection, including active surveillance and radiofrequency ablation. To inform shared decision-making and comparative-effectiveness models, treatment preferences\/quality of life quantified by health utilities must be derived for PTMC. However, there is ambiguity regarding the population from which these should be elicited. We aimed to compare health state utility estimates for PTMC as derived from general population volunteers (GenPop) and thyroid cancer survivors (TCSurv).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>GenPop and TCSurv completed a time trade-off task for 10 PTMC health states described by clinical vignettes. Health utilities were compared between groups with univariate and multivariable linear regression, adjusting for age, sex, and income. Subgroup analysis was performed for health states with and without treatment complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>70 GenPop and 72 TCSurv completed the surveys. GenPop reported lower utilities relative to TCSurv for all 10 health states, with an effect size of 0.044 attributed to participant group in the multivariable analysis (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). This observation persisted in stratified analysis by treatment complication, with effect sizes 0.047 (<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and 0.042 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) for uncomplicated and complicated groups, respectively. Health utilities were lower for complicated scenarios (effect size 0.067, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) compared to uncomplicated scenarios.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>For 10 low-risk thyroid cancer health states, GenPop reported significantly lower health utilities than TCSurv. Health economists and healthcare delivery scientists should be aware of these differences when integrating health utilities into comparative-effectiveness research.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11136-025-04033-7","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T14:17:52Z","timestamp":1755958672000},"page":"2891-2900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differences in health state valuation for small, low-risk thyroid cancer between general population and cancer survivors: a cross-sectional analysis"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-3686","authenticated-orcid":false,"given":"Kendyl","family":"Carlisle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-3710","authenticated-orcid":false,"given":"Rebecca","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1697-9581","authenticated-orcid":false,"given":"Aprill N.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0156-3591","authenticated-orcid":false,"given":"Salome","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6786-5477","authenticated-orcid":false,"given":"Carrie","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6900-9220","authenticated-orcid":false,"given":"Julia F.","family":"Slejko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4322-2490","authenticated-orcid":false,"given":"C. Daniel","family":"Mullins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-9530","authenticated-orcid":false,"given":"Yinin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"4033_CR1","unstructured":"American Cancer Society (2023, August 23). Thyroid Cancer Survival Rates, by Type and Stage. Retrieved December 17, 2024, from https:\/\/www.cancer.org\/cancer\/types\/thyroid-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"issue":"1","key":"4033_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/lio2.356","volume":"5","author":"S Lohia","year":"2020","unstructured":"Lohia, S., Hanson, M., Tuttle, R. M., & Morris, L. G. T. (2020). Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope Investigative Otolaryngology, 5(1), 175\u2013182. https:\/\/doi.org\/10.1002\/lio2.356","journal-title":"Laryngoscope Investigative Otolaryngology"},{"issue":"1","key":"4033_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., Schuff, K. G., Sherman, S. I., Sosa, J. A., Steward, D. L., Tuttle, R. M., & Wartofsky, L. (2016). 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid Cancer. Thyroid: official Journal of the American Thyroid Association, 26(1), 1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid: official Journal of the American Thyroid Association"},{"issue":"1","key":"4033_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.amjsurg.2020.11.021","volume":"222","author":"AD McDow","year":"2021","unstructured":"McDow, A. D., Roman, B. R., Saucke, M. C., Jensen, C. B., Zaborek, N., Jennings, J. L., Davies, L., Brito, J. P., & Pitt, S. C. (2021). Factors associated with physicians\u2019 recommendations for managing low-risk papillary thyroid cancer. American Journal of Surgery, 222(1), 111\u2013118. https:\/\/doi.org\/10.1016\/j.amjsurg.2020.11.021","journal-title":"American Journal of Surgery"},{"issue":"1","key":"4033_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1477-7525-1-80","volume":"1","author":"L Prieto","year":"2003","unstructured":"Prieto, L., & Sacrist\u00e1n, J. A. (2003). Problems and solutions in calculating quality-adjusted life years (QALYs). Health and Quality of Life Outcomes, 1(1), 80. https:\/\/doi.org\/10.1186\/1477-7525-1-80","journal-title":"Health and Quality of Life Outcomes"},{"issue":"2","key":"4033_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.2016.0260","volume":"27","author":"CC Lubitz","year":"2017","unstructured":"Lubitz, C. C., De Gregorio, L., Fingeret, A. L., Economopoulos, K. P., Termezawi, D., Hassan, M., Parangi, S., Stephen, A. E., Halpern, E. F., Donelan, K., & Swan, J. S. (2017). Measurement and variation in Estimation of quality of life effects of patients undergoing treatment for papillary thyroid carcinoma. Thyroid: official Journal of the American Thyroid Association, 27(2), 197\u2013206. https:\/\/doi.org\/10.1089\/thy.2016.0260","journal-title":"Thyroid: official Journal of the American Thyroid Association"},{"issue":"3","key":"4033_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s11136-020-02676-2","volume":"30","author":"R Houten","year":"2021","unstructured":"Houten, R., Fleeman, N., Kotas, E., Boland, A., Lambe, T., & Duarte, R. (2021). A systematic review of health state utility values for thyroid cancer. Quality of Life Research, 30(3), 675\u2013702. https:\/\/doi.org\/10.1007\/s11136-020-02676-2","journal-title":"Quality of Life Research"},{"issue":"4","key":"4033_CR8","doi-asserted-by":"publisher","first-page":"E57","DOI":"10.1177\/0272989X10370488","volume":"30","author":"A Gandjour","year":"2010","unstructured":"Gandjour, A. (2010). Theoretical foundation of patient v. population preferences in calculating QALYs. Medical Decision Making, 30(4), E57\u2013E63. https:\/\/doi.org\/10.1177\/0272989X10370488","journal-title":"Medical Decision Making"},{"issue":"8","key":"4033_CR9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2165\/11588250-000000000-00000","volume":"29","author":"M Garau","year":"2011","unstructured":"Garau, M., Shah, K. K., Mason, A. R., Wang, Q., Towse, A., & Drummond, M. F. (2011). Using QALYs in cancer: A review of the methodological limitations. Pharmacoeconomics, 29(8), 673\u2013685. https:\/\/doi.org\/10.2165\/11588250-000000000-00000","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"4033_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jval.2010.10.015","volume":"14","author":"JC Tosh","year":"2011","unstructured":"Tosh, J. C., Longworth, L. J., & George, E. (2011). Utility values in national institute for health and clinical excellence (NICE) technology appraisals. Value in Health, 14(1), 102\u2013109. https:\/\/doi.org\/10.1016\/j.jval.2010.10.015","journal-title":"Value in Health"},{"issue":"2","key":"4033_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1524-4733.2009.00610.x","volume":"13","author":"Y Peeters","year":"2010","unstructured":"Peeters, Y., & Stiggelbout, A. M. (2010). Health state valuations of patients and the general public analytically compared: A meta-analytical comparison of patient and population health state utilities. Value in Health, 13(2), 306\u2013309. https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00610.x","journal-title":"Value in Health"},{"issue":"12","key":"4033_CR12","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1007\/s11136-017-1683-5","volume":"26","author":"M Gandhi","year":"2017","unstructured":"Gandhi, M., Tan, R. S., Ng, R., Choo, S. P., Chia, W. K., Toh, C. K., Lam, C., Lee, P. T., Latt, N. K. Z., Rand-Hendriksen, K., Cheung, Y. B., & Luo, N. (2017). Comparison of health state values derived from patients and individuals from the general population. Quality of Life Research, 26(12), 3353\u20133363. https:\/\/doi.org\/10.1007\/s11136-017-1683-5","journal-title":"Quality of Life Research"},{"key":"4033_CR13","doi-asserted-by":"publisher","unstructured":"Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (1996). Whose preferences should be used in CEA? Cost-Effectiveness in health and medicine (pp. 98\u2013105). Oxford University Press. https:\/\/doi.org\/10.1093\/oso\/9780195108248.001.0001","DOI":"10.1093\/oso\/9780195108248.001.0001"},{"issue":"5","key":"4033_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/0272989X211065471","volume":"42","author":"MN Kaur","year":"2022","unstructured":"Kaur, M. N., Yan, J., Klassen, A. F., David, J. P., Pieris, D., Sharma, M., Bordeleau, L., & Xie, F. (2022). A systematic literature review of health utility values in breast cancer. Medical Decision Making: an International Journal of the Society for Medical Decision Making, 42(5), 704\u2013719. https:\/\/doi.org\/10.1177\/0272989X211065471","journal-title":"Medical Decision Making: an International Journal of the Society for Medical Decision Making"},{"key":"4033_CR15","unstructured":"Kowalski, R., Carlisle, K., Park, A., Ricci, S., Don, R., Cunningham, C., Slejko, J. F., Mullins, C. D., & Hu, Y. (2025). Estimation of QALY weights for PTMC treatment pathways by thyroid cancer survivors. Surgery (in press)."},{"issue":"1","key":"4033_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40271-022-00597-5","volume":"16","author":"EG Roth","year":"2023","unstructured":"Roth, E. G., Kim, J., Slejko, J. F., Mullins, C. D., Doyle, J. L., Levitt, D. L., Melendez, M., Fletke, K. J., & Hu, Y. (2023). Constructing health state descriptions for low-risk thyroid cancer: Stakeholder engagement and formative qualitative research. The Patient, 16(1), 67\u201376. https:\/\/doi.org\/10.1007\/s40271-022-00597-5","journal-title":"The Patient"},{"key":"4033_CR17","doi-asserted-by":"publisher","first-page":"117001","DOI":"10.1016\/j.socscimed.2024.117001","volume":"351","author":"M Tour\u00e9","year":"2024","unstructured":"Tour\u00e9, M., & Poder, T. G. (2024). Differences in health utilities between cancer patients and the general population: The case of Quebec using the SF-6Dv2. Social Science & Medicine, 351, 117001. https:\/\/doi.org\/10.1016\/j.socscimed.2024.117001","journal-title":"Social Science & Medicine"},{"issue":"10","key":"4033_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","volume":"34","author":"M Oppe","year":"2016","unstructured":"Oppe, M., Rand-Hendriksen, K., Shah, K., Ramos-Go\u00f1i, J. M., & Luo, N. (2016). EuroQol protocols for time trade-off valuation of health outcomes. Pharmacoeconomics, 34(10), 993\u20131004. https:\/\/doi.org\/10.1007\/s40273-016-0404-1","journal-title":"Pharmacoeconomics"},{"issue":"2","key":"4033_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jval.2015.11.012","volume":"19","author":"KS Gries","year":"2016","unstructured":"Gries, K. S., Regier, D. A., Ramsey, S. D., & Patrick, D. L. (2016). Preferences for prostate cancer outcomes: A comparison of the patient perspective, the general population perspective, and a population at risk for prostate Cancer. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 19(2), 218\u2013225. https:\/\/doi.org\/10.1016\/j.jval.2015.11.012","journal-title":"Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research"},{"key":"4033_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.socscimed.2016.07.043","volume":"165","author":"MM Versteegh","year":"2016","unstructured":"Versteegh, M. M., & Brouwer, W. B. F. (2016). Patient and general public preferences for health states: A call to reconsider current guidelines. Social Science & Medicine, 165, 66\u201374. https:\/\/doi.org\/10.1016\/j.socscimed.2016.07.043","journal-title":"Social Science & Medicine"},{"issue":"1","key":"4033_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1524-4733.2007.00216.x","volume":"11","author":"AM Stiggelbout","year":"2008","unstructured":"Stiggelbout, A. M., & De Vogel-Voogt, E. (2008). Health state utilities: A framework for studying the gap between the imagined and the real. Value in Health, 11(1), 76\u201387. https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00216.x","journal-title":"Value in Health"},{"issue":"1","key":"4033_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1037\/hea0000806","volume":"39","author":"RP Murphy","year":"2020","unstructured":"Murphy, R. P., Boyce, C. J., Dolan, P., & Wood, A. M. (2020). Valuing the Q in qalys: Does providing patients\u2019 ratings affect population values?? Health Psychology, 39(1), 37\u201345. https:\/\/doi.org\/10.1037\/hea0000806","journal-title":"Health Psychology"},{"issue":"6","key":"4033_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamaoto.2022.0621","volume":"148","author":"V Hsiao","year":"2022","unstructured":"Hsiao, V., Light, T. J., Adil, A. A., Tao, M., Chiu, A. S., Hitchcock, M., Arroyo, N., Fernandes-Taylor, S., & Francis, D. O. (2022). Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: A systematic review and meta-analysis. JAMA Otolaryngology - Head and Neck Surgery, 148(6), 531\u2013539. https:\/\/doi.org\/10.1001\/jamaoto.2022.0621","journal-title":"JAMA Otolaryngology - Head and Neck Surgery"},{"issue":"5","key":"4033_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4174\/jkss.2012.83.5.259","volume":"83","author":"JS Cho","year":"2012","unstructured":"Cho, J. S., Yoon, J. H., Park, M. H., Shin, S. H., Jegal, Y. J., Lee, J. S., & Kim, H. K. (2012). Age and prognosis of papillary thyroid carcinoma: Retrospective stratification into three groups. Journal of the Korean Surgical Society, 83(5), 259\u2013266. https:\/\/doi.org\/10.4174\/jkss.2012.83.5.259","journal-title":"Journal of the Korean Surgical Society"},{"issue":"4","key":"4033_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3803\/EnM.2022.1499","volume":"37","author":"J Lee","year":"2022","unstructured":"Lee, J., Lee, Y. J., Lim, D. J., Lee, J. M., Chang, S. A., & Kim, M. H. (2022). Quality of life of survivors of thyroid cancer is not inferior to that in subjects without cancer: Long-term after over 5 years. Endocrinology and Metabolism, 37(4), 664\u2013673. https:\/\/doi.org\/10.3803\/EnM.2022.1499","journal-title":"Endocrinology and Metabolism"},{"issue":"4","key":"4033_CR26","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1365-2265.2011.04114.x","volume":"75","author":"O Husson","year":"2011","unstructured":"Husson, O., Haak, H. R., Oranje, W. A., Mols, F., Reemst, P. H. M., & van de Poll-Franse, L. V. (2011). Health\u2010related quality of life among thyroid cancer survivors: A systematic review. Clinical Endocrinology, 75(4), 544\u2013554. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04114.x","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"4033_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2265.2008.03366.x","volume":"70","author":"H Pelttari","year":"2009","unstructured":"Pelttari, H., Sintonen, H., Schalin-J\u00e4ntti, C., & V\u00e4lim\u00e4ki, M. J. (2009). Health\u2010related quality of life in long\u2010term follow\u2010up of patients with cured TNM stage I or II differentiated thyroid carcinoma. Clinical Endocrinology, 70(3), 493\u2013497. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03366.x","journal-title":"Clinical Endocrinology"},{"key":"4033_CR28","unstructured":"U.S. Census Bureau. (n.d.). Nation: United States. U.S. Census Bureau. Retrieved May 19 (2025). from https:\/\/data.census.gov\/profile\/United_States?g=010XX00US"},{"issue":"3","key":"4033_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/eurpub\/9.3.211","volume":"9","author":"L Lundberg","year":"1999","unstructured":"Lundberg, L., Johannesson, M., Isacson, D. G. L., & Borgquist, L. (1999). Health-state utilities in a general population in relation to age, gender and socioeconomic factors. European Journal of Public Health, 9(3), 211\u2013217. https:\/\/doi.org\/10.1093\/eurpub\/9.3.211","journal-title":"European Journal of Public Health"},{"issue":"2","key":"4033_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/(SICI)1099-1050","volume":"5","author":"P Dolan","year":"1996","unstructured":"Dolan, P., Gudex, C., Kind, P., & Williams, A. (1996). The time trade-off method: Results from a general population study. Health Economics, 5(2), 141\u2013154. https:\/\/doi.org\/10.1002\/(SICI)1099-1050::AID-HEC189>3.0.CO;2-N.","journal-title":"Health Economics"},{"issue":"7","key":"4033_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.eprac.2023.04.008","volume":"29","author":"J Kim","year":"2023","unstructured":"Kim, J., Roth, E. G., Carlisle, K., Munir, K. M., Fletke, K. J., Slejko, J. F., Mullins, C. D., & Hu, Y. (2023). Eliciting low-risk thyroid Cancer treatment preferences using clinical vignettes: A pilot study. Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(7), 525\u2013528. https:\/\/doi.org\/10.1016\/j.eprac.2023.04.008","journal-title":"Endocrine Practice: Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"issue":"4","key":"4033_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14737167.2020.1779062","volume":"20","author":"AK Lugn\u00e9r","year":"2020","unstructured":"Lugn\u00e9r, A. K., & Krabbe, P. F. M. (2020). An overview of the time trade-off method: Concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Review of Pharmacoeconomics and Outcomes Research, 20(4), 331\u2013342. https:\/\/doi.org\/10.1080\/14737167.2020.1779062","journal-title":"Expert Review of Pharmacoeconomics and Outcomes Research"},{"key":"4033_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1477-7525-12-48","volume":"12","author":"LS Matza","year":"2014","unstructured":"Matza, L. S., Boye, K. S., Feeny, D. H., Johnston, J. A., Bowman, L., & Jordan, J. B. (2014). Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions. Health and Quality of Life Outcomes, 12, 48. https:\/\/doi.org\/10.1186\/1477-7525-12-48","journal-title":"Health and Quality of Life Outcomes"},{"issue":"4","key":"4033_CR34","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s11136-021-03026-6","volume":"31","author":"TM Hansen","year":"2022","unstructured":"Hansen, T. M., Stavem, K., & Rand, K. (2022). Time trade-off with someone to live for: Impact of having significant others on time trade-off valuations of hypothetical health States. Quality of Life Research, 31(4), 1199\u20131207. https:\/\/doi.org\/10.1007\/s11136-021-03026-6","journal-title":"Quality of Life Research"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-04033-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-025-04033-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-04033-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:08:00Z","timestamp":1760962080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-025-04033-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4033"],"URL":"https:\/\/doi.org\/10.1007\/s11136-025-04033-7","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"11 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed by the University of Maryland IRB and determined to be exempt (project reference number: HP-00093873).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Verbal informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}